Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117285) titled 'Clinical efficacy and mechanism study of bilateral sequential accelerated TBS therapy for refractory depression' on Jan. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Kangning Hospital of Ningbo University
Condition:
Depressive
Intervention:
Bilateral sequential accelerated true TBS group:Active stimulation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-30
Target Sample Size: Bilateral sequential accelerated true TBS group:50;Bilateral sequential acceleration pseudo-TBS group:50;
Countries of Recruitment:
China
To know more...